Show simple item record

dc.contributor.authorAllen, Wendy L.
dc.contributor.authorDunne, Philip D.
dc.contributor.authorMcDade, Simon
dc.contributor.authorScanlon, Enya
dc.contributor.authorLoughrey, Maurice
dc.contributor.authorColeman, Helen G.
dc.contributor.authorMcCann, Christophe
dc.contributor.authorMcLaughlin, Kristy
dc.contributor.authorNemeth, Zsuzsanna
dc.contributor.authorSyed, Najeeb Ashraf
dc.contributor.authorJithesh, Puthen Veettil
dc.contributor.authorArthur, Ken
dc.contributor.authorWilson, Richard
dc.contributor.authorCoyle, Vicky M.
dc.contributor.authorMcArt, Darragh
dc.contributor.authorMurray, Graeme L.
dc.contributor.authorSamuel, Leslie
dc.contributor.authorNuciforo, Paolo
dc.contributor.authorJimenez, Jose
dc.contributor.authorArgiles, Guillem
dc.contributor.authorDienstmann, Rodrigo
dc.contributor.authorTabernero, Josef
dc.contributor.authorPicariello, Lucia
dc.contributor.authorMesserini, Luca
dc.contributor.authorNobili, Stefania
dc.contributor.authorMini, Enrico
dc.contributor.authorSheahan, Kieran
dc.contributor.authorRyan, Elizabeth
dc.contributor.authorJohnston, Patrick G.
dc.contributor.authorVan Schaeybroeck, Sandra
dc.contributor.authorLawler, Mark
dc.contributor.authorLongley, Daniel B.
dc.date.accessioned2018-06-20T23:08:53Z
dc.date.available2018-06-20T23:08:53Z
dc.date.issued2018-06-13
dc.identifier.citationAllen , W L , Dunne , P D , McDade , S , Scanlon , E , Loughrey , M , Coleman , H G , McCann , C , McLaughlin , K , Nemeth , Z , Syed , N A , Jithesh , P V , Arthur , K , Wilson , R , Coyle , V M , McArt , D , Murray , G L , Samuel , L , Nuciforo , P , Jimenez , J , Argiles , G , Dienstmann , R , Tabernero , J , Picariello , L , Messerini , L , Nobili , S , Mini , E , Sheahan , K , Ryan , E , Johnston , P G , Van Schaeybroeck , S , Lawler , M & Longley , D B 2018 , ' Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy ' , JCO Precision Oncology , vol. 2 , pp. 1-15 . https://doi.org/10.1200/PO.17.00241en
dc.identifier.issn2473-4284
dc.identifier.otherPURE: 118877019
dc.identifier.otherPURE UUID: a637df67-9870-4c9a-999c-cce4c8d63f49
dc.identifier.otherORCID: /0000-0002-8402-8670/work/50559782
dc.identifier.otherORCID: /0000-0003-3981-2420/work/76973564
dc.identifier.otherScopus: 85083938497
dc.identifier.otherPubMed: 30088816
dc.identifier.otherPubMedCentral: PMC6040635
dc.identifier.urihttp://hdl.handle.net/2164/10636
dc.descriptionThis work was funded by Cancer Research UK: C212/A13721 and C11884/A24387en
dc.format.extent15
dc.language.isoeng
dc.relation.ispartofJCO Precision Oncologyen
dc.rights© 2018 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectCancer Research UKen
dc.subjectC212/A13721en
dc.subjectC11884/A24387en
dc.subjectSupplementary Dataen
dc.subject.lccRC0254en
dc.titleTranscriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1200/PO.17.00241


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record